ML14251A145: Difference between revisions
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
StriderTol (talk | contribs) (Created page by program invented by StriderTol) |
||
(One intermediate revision by the same user not shown) | |||
Line 3: | Line 3: | ||
| issue date = 09/15/2014 | | issue date = 09/15/2014 | ||
| title = Response to 03/26/2014, Nuclear Energy Institute Letter on Dermal and Ocular Quantitative Exposure Standard | | title = Response to 03/26/2014, Nuclear Energy Institute Letter on Dermal and Ocular Quantitative Exposure Standard | ||
| author name = Bailey M | | author name = Bailey M | ||
| author affiliation = NRC/NMSS/FCSS | | author affiliation = NRC/NMSS/FCSS | ||
| addressee name = Schlueter J | | addressee name = Schlueter J | ||
| addressee affiliation = Nuclear Energy Institute (NEI) | | addressee affiliation = Nuclear Energy Institute (NEI) | ||
| docket = 07001257 | | docket = 07001257 | ||
| license number = SNM-1227 | | license number = SNM-1227 | ||
| contact person = Diaz M | | contact person = Diaz M | ||
| package number = ML14251A150 | | package number = ML14251A150 | ||
| document type = Letter | | document type = Letter | ||
Line 16: | Line 16: | ||
=Text= | =Text= | ||
{{#Wiki_filter:September 15, 2014 Ms. Janet R. Schlueter, Director Fuel and Materials Safety Nuclear Generation Division Nuclear Energy Institute 1201 F Street, NW Suite 1100 Washington, DC | {{#Wiki_filter:September 15, 2014 Ms. Janet R. Schlueter, Director Fuel and Materials Safety Nuclear Generation Division Nuclear Energy Institute 1201 F Street, NW Suite 1100 Washington, DC 20004 | ||
==SUBJECT:== | ==SUBJECT:== | ||
RESPONSE TO MARCH 26, 2014, NUCLEAR ENERGY INSTITUTE LETTER ON DERMAL AND OCULAR QUANTITATIVE EXPOSURE STANDARD | RESPONSE TO MARCH 26, 2014, NUCLEAR ENERGY INSTITUTE LETTER ON DERMAL AND OCULAR QUANTITATIVE EXPOSURE STANDARD | ||
==Dear Ms. Schlueter:== | ==Dear Ms. Schlueter:== | ||
The U.S. Nuclear Regulatory Commission (NRC) staff has reviewed your letter dated March 26, 2014, and its enclosure, arguing that the Integrated Safety Analysis (ISA) need only consider inhalation pathways when analyzing for acute chemical exposures to NRC-licensed material, or chemicals produced from such material. You state that developing dermal and ocular exposure standards for use in demonstrating compliance with the performance requirements of Title 10 of the Code of Federal Regulations (10 CFR) Part 70, Subpart H, | The U.S. Nuclear Regulatory Commission (NRC) staff has reviewed your letter dated March 26, 2014, and its enclosure, arguing that the Integrated Safety Analysis (ISA) need only consider inhalation pathways when analyzing for acute chemical exposures to NRC-licensed material, or chemicals produced from such material. You state that developing dermal and ocular exposure standards for use in demonstrating compliance with the performance requirements of Title 10 of the Code of Federal Regulations (10 CFR) Part 70, Subpart H, is impractical, unnecessary and constitutes an unanalyzed backfit. The staff has reviewed the NRC documentation supporting the development of the Subpart H rule, and finds that the rules requirements for analyzing chemical hazards (specifically, hazards arising from acute chemical exposures) are not limited to consideration of the inhalation pathway. The staff concludes that failure to consider all reasonable worker exposure pathways would create a regulatory gap in the oversight of chemical hazards that are under NRCs jurisdiction. | ||
Neither the relevant Subpart H requirements, nor the NRCs interpretation of these requirements, have changed. However, even if the staffs position on dermal and ocular exposure pathways is deemed to be the imposition of a new regulatory position that falls within the definition of backfitting, the compliance exception stated in 10 CFR 70.76(a)(4)(i) would be applicable. The enclosure to this letter provides a detailed evaluation of the compliance backfit exception. | |||
Accordingly, the staff will evaluate ISA summaries to ensure that the licensee has considered all reasonable exposure pathways in the ISA chemical hazard analysis. For all credible event consequences as defined in 10 CFR 70.61(b)(4) and (c)(4), the staff will review the ISA summary description of the proposed quantitative standards used to assess the consequences to an individual from acute chemical exposure to licensed material or chemicals produced from licensed materials, as stated in 10 CFR 70.65(b)(7). For license amendments, renewals or new applications such staff evaluations do not constitute backfitting. | |||
The NRC is developing an Interim Staff Guidance (ISG) that addresses chemical exposures at fuel cycle facilities subject to Subpart H. The ISG will discuss the criteria staff will apply when reviewing event consequences and proposed quantitative standards used to assess the consequences to an individual from acute chemical exposure in the ISA. The ISG will provide | |||
J. Schlueter guidance on the staff review of all credible exposure pathways to demonstrate compliance with 10 CFR 70.61. Development of this ISG should help promote a common understanding of proposed quantitative standards for non-inhalation pathways supporting chemical safety analyses in the ISA. The NRC will engage stakeholders, as appropriate, to discuss an implementation plan. | |||
In accordance with 10 CFR 2.390 of the NRCs Agency Rules of Practice and Procedure, a copy of this letter will be available electronically for public inspection in the NRC Public Document Room or from the Publicly Available Records component of NRCs Agencywide Documents Access and Management System (ADAMS). ADAMS is accessible from the NRC Web site at http://www.nrc.gov/reading-rm/adams.html. | |||
Sincerely, | |||
/RA/ | |||
Marissa G. Bailey, Director A.Blamey-for Division of Fuel Cycle Safety and Safeguards Office of Nuclear Material Safety and Safeguards Docket: 70-1257 License: SNM-1227 | |||
guidance on the staff review of all credible exposure pathways to demonstrate compliance with 10 CFR 70.61. Development of this ISG should help promote a common understanding of proposed quantitative standards for non-inhalation pathways supporting chemical safety analyses in the ISA. The NRC will engage stakeholders, as appropriate, to discuss an implementation plan. | |||
In accordance with 10 CFR 2.390 of the | |||
Marissa G. Bailey, Director | |||
Docket: | |||
==Enclosure:== | ==Enclosure:== | ||
Documented Evaluation for Compliance Backfit Exception | Documented Evaluation for Compliance Backfit Exception | ||
ML14251A145 Pkg.: | ML14251A145 Pkg.: ML14251A150 OFFICE FCSS/FMB FCSS/FMB/LA FCSS/FMB/BC OGC FCSS/DD NAME MDiaz TBrockington RJohnson JHull MBailey DATE 09/08/14 09/12/14 09/08/14 09/15/14 09/15 /14}} |
Latest revision as of 00:38, 4 November 2019
ML14251A145 | |
Person / Time | |
---|---|
Site: | Framatome ANP Richland |
Issue date: | 09/15/2014 |
From: | Marissa Bailey NRC/NMSS/FCSS |
To: | Schlueter J Nuclear Energy Institute |
Diaz M | |
Shared Package | |
ML14251A150 | List: |
References | |
Download: ML14251A145 (3) | |
Text
September 15, 2014 Ms. Janet R. Schlueter, Director Fuel and Materials Safety Nuclear Generation Division Nuclear Energy Institute 1201 F Street, NW Suite 1100 Washington, DC 20004
SUBJECT:
RESPONSE TO MARCH 26, 2014, NUCLEAR ENERGY INSTITUTE LETTER ON DERMAL AND OCULAR QUANTITATIVE EXPOSURE STANDARD
Dear Ms. Schlueter:
The U.S. Nuclear Regulatory Commission (NRC) staff has reviewed your letter dated March 26, 2014, and its enclosure, arguing that the Integrated Safety Analysis (ISA) need only consider inhalation pathways when analyzing for acute chemical exposures to NRC-licensed material, or chemicals produced from such material. You state that developing dermal and ocular exposure standards for use in demonstrating compliance with the performance requirements of Title 10 of the Code of Federal Regulations (10 CFR) Part 70, Subpart H, is impractical, unnecessary and constitutes an unanalyzed backfit. The staff has reviewed the NRC documentation supporting the development of the Subpart H rule, and finds that the rules requirements for analyzing chemical hazards (specifically, hazards arising from acute chemical exposures) are not limited to consideration of the inhalation pathway. The staff concludes that failure to consider all reasonable worker exposure pathways would create a regulatory gap in the oversight of chemical hazards that are under NRCs jurisdiction.
Neither the relevant Subpart H requirements, nor the NRCs interpretation of these requirements, have changed. However, even if the staffs position on dermal and ocular exposure pathways is deemed to be the imposition of a new regulatory position that falls within the definition of backfitting, the compliance exception stated in 10 CFR 70.76(a)(4)(i) would be applicable. The enclosure to this letter provides a detailed evaluation of the compliance backfit exception.
Accordingly, the staff will evaluate ISA summaries to ensure that the licensee has considered all reasonable exposure pathways in the ISA chemical hazard analysis. For all credible event consequences as defined in 10 CFR 70.61(b)(4) and (c)(4), the staff will review the ISA summary description of the proposed quantitative standards used to assess the consequences to an individual from acute chemical exposure to licensed material or chemicals produced from licensed materials, as stated in 10 CFR 70.65(b)(7). For license amendments, renewals or new applications such staff evaluations do not constitute backfitting.
The NRC is developing an Interim Staff Guidance (ISG) that addresses chemical exposures at fuel cycle facilities subject to Subpart H. The ISG will discuss the criteria staff will apply when reviewing event consequences and proposed quantitative standards used to assess the consequences to an individual from acute chemical exposure in the ISA. The ISG will provide
J. Schlueter guidance on the staff review of all credible exposure pathways to demonstrate compliance with 10 CFR 70.61. Development of this ISG should help promote a common understanding of proposed quantitative standards for non-inhalation pathways supporting chemical safety analyses in the ISA. The NRC will engage stakeholders, as appropriate, to discuss an implementation plan.
In accordance with 10 CFR 2.390 of the NRCs Agency Rules of Practice and Procedure, a copy of this letter will be available electronically for public inspection in the NRC Public Document Room or from the Publicly Available Records component of NRCs Agencywide Documents Access and Management System (ADAMS). ADAMS is accessible from the NRC Web site at http://www.nrc.gov/reading-rm/adams.html.
Sincerely,
/RA/
Marissa G. Bailey, Director A.Blamey-for Division of Fuel Cycle Safety and Safeguards Office of Nuclear Material Safety and Safeguards Docket: 70-1257 License: SNM-1227
Enclosure:
Documented Evaluation for Compliance Backfit Exception
ML14251A145 Pkg.: ML14251A150 OFFICE FCSS/FMB FCSS/FMB/LA FCSS/FMB/BC OGC FCSS/DD NAME MDiaz TBrockington RJohnson JHull MBailey DATE 09/08/14 09/12/14 09/08/14 09/15/14 09/15 /14